Ascertainment and evaluation of interval cancers in population-based mammography screening programmes: A collaborative study in four European centres

Journal of Medical Screening

Volumn 12, Issue 1, 2005, Pages 43-49

  Törnberg, Sven ^a   Codd, Mary ^b   Rodrigues, Vitor ^c   Segnan, Nereo ^d   Ponti, Antonio ^d  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^c Liga Portuguese Contra o Cancro   (Portugal)

^d CPO Piemonte   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; EUROPE; EVALUATION; FEMALE; GROUPS BY AGE; HEALTH CARE ORGANIZATION; HEALTH CARE SYSTEM; HUMAN; IRELAND; ITALY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASS SCREENING; OUTCOMES RESEARCH; POISSON DISTRIBUTION; PORTUGAL; SWEDEN;

BREAST NEOPLASMS; COOPERATIVE BEHAVIOR; DATA INTERPRETATION, STATISTICAL; EUROPE; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; REGISTRIES; TIME FACTORS;

EID: 15944386385     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1258/0969141053279077     Document Type: Article

References (30)

1. Kirkpartick A, Törnberg S, de Wolf C, eds. European Guidelines for Quality Assurance in Mammography Screening. Luxembourg: Europe Against Cancer, European Commission, 1993
2. de Wolf C, Perry N, eds. European Guidelines for Quality Assurance in Mammography Screening. 2nd edn. Luxembourg: Europe Against Cancer, European Commission, 1996
3. Perry N, Breeders M, de Wolf C, et al., eds. European Guidelines for Quality Assurance in Mammography Screening. 3rd edn. Luxembourg: Europe Against Cancer, European Commission, 2001
4. Fagerberg G, Baldetorp L, Grontoft O, et al. Effects of repeated mammographic screening on breast cancer stage distribution. Results from a randomised study of 92 934 women in a Swedish county. Acta Radiol Oncol 1985;24:465-73
5. Frisell J, Lidbrink E, Hellstrom L, et al. Followup after 11 years - update of mortality results in the Stockholm mammographic screening trial. Breast Cancer Res Treat 1997;45:263-70
6. Ikeda DM, Andersson I, Wattsgard C, et al. Interval carcinomas in the Malmo Mammographic Screening Trial: radiographic appearance and prognostic considerations. Am J Roentgenol 1992;159:287-94
7. Lynge E. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group. APMIS Suppl 1998;83:1-44
8. Miller AB, Baines CJ, To T, et al. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. CMAJ 1992;147:1477-38
9. Pad E, Ciatto S, Buiatti E, et al. Early indicators of efficacy of breast cancer screening programmes. Results of the Florence District Programme. Int J Cancer 1990;46:198-202
10. Rickard MT, Taylor RJ, Fazli MA, et al. Interval breast cancers in an Australian mammographic screening program. Med J Aust 1998;169:184-7
11. Tabar L, Faberberg G, Day NE, et al. What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer 1987;55:547-51
12. Wang H, Bjurstam N, Bjorndal H, et al. Interval cancers in the Norwegian breast cancer screening program: frequency, characteristics and use of HRT. Int J Cancer 2001;94:594-8
13. Taylor R, Supramaniam R, Rickard M, et al. Interval breast cancers in New South Wales, Australia, and comparisons with trials and other mammographic screening programmes. J Med Screen 2002;9:20-5
14. Brekelmans CT, Peeters PH, Faber JA, et al. The epidemiological profile of women with an interval cancer in the DOM screening programme. Breast Cancer Res Treat 1994;30:223-32
15. Everington D, Gilbert FJ, Tyack C, et al. The Scottish breast screening programme's experience of monitoring interval cancers. J Med Screen 1999;6:21-7
16. Fracheboud J, de Koning HJ, Beemsterboer PM, et al. Interval cancers in the Dutch breast cancer screening programme. Br J Cancer 1999;81:912-7
17. Kavanagh AM, Mitchell H, Farrugia H, et al. Monitoring interval cancers in an Australian mammographic screening programme. J Med Screen 1999;6:139-43
18. Vitak B, Olsen KE, Manson JC, et al. Tumour characteristics and survival in patients with invasive interval breast cancer classified according to mammographic findings at the latest screening: a comparison of true interval and missed interval cancers. Eur Radiol 1999;9:460-9
19. Alves JG, Cruz DB, Rodrigues VL, et al. Breast cancer screening in the central region of Portugal. Eur J Cancer Prev 1994;3(Suppl 1):49-53
20. Ascunce N, del Moral A, Murillo A, et al. Early detection programme for breast cancer in Navarra, Spain. Eur J Cancer Prev 1994;3(Suppl 1): 41-8
21. Codd MB, Laird OM, Dowling M, et al. Screening for breast cancer in Ireland: the Eccles Breast Screening Programme. Eur J Cancer Prev 1994;3(Suppl 1):21-8
22. Garas I, Pateras H, Triandafilou D, et al. Breast cancer screening in southern Greece. Eur J Cancer Prev 1994;3(Suppl 1):35-9
23. Renaud R, Gairard B, Schaffer P, et al. Europe against cancer. Breast cancer screening programme in France: the ADEMAS programme in Bas-Rhin. Eur J Cancer Prev 1994;3(Suppl 1):13-9
24. Van Oyen H, Verellen W. Breast cancer screening in the Flemish region, Belgium. Eur J Cancer Prev 1994;3(Suppl 1):7-12
25. Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 1984;23:305-13
26. Moss SM, Coleman DA, Ellman R, et al. Interval cancers and sensitivity in the screening centres of the UK trial of early detection of breast cancer. Eur J Cancer 1993;29A:255-8
27. Sylvester PA, Kutt E, Baird A, et al. Rate and classification of interval cancers in the breast screening programme. Ann R Coll Surg Engl 1997;79:276-7
28. Tange UB, Hirsch FR, Jensen MB, et al. Mammography screening in the county of Copenhagen - results of the first three screening rounds. Ugeskr Laeger 2002;164:1048-52
29. Thurfjell EL, Lindgren JA. Population-based mammography screening in Swedish clinical practice: prevalence and incidence screening in Uppsala County. Radiology 1994;193:351-7
30. Vitak B. Invasive interval cancers in the Ostergotland Mammographic Screening Programme: radiological analysis. Eur Radiol 1998;8: 639-46